(1) Price trends for the list of prescription drugs provided to the board by the Department of Consumer and Business Services under ORS 646A.694 (1);
(2) The prescription drugs that were reviewed under ORS 646A.694 (1); and
(3) Recommendations, if any, for legislative changes necessary to make prescription drug products more affordable in this state. [2021 c.598 §5]